Year archive

Vaxcell-Bio Therapeutics — 2024 filings

All 56 regulatory filings released by Vaxcell-Bio Therapeutics (323990) in 2024, sourced directly from the official regulator.

56 Filings

2024 Period

2024 filings (56)

Filing	Released	Lang
합병등종료보고서(합병) M&A Activity	2024-12-26	Korean
주주명부폐쇄기간또는기준일설정 Notice of Dividend Amount	2024-12-13	Korean
투자판단관련주요경영사항 (박스루킨15주 (Vaxleukin15 inj) 품목허가변경신청 (적응증 확대 및 유효기간, 제조방법 변경)) Regulatory Filings	2024-12-02	Korean
기타경영사항(자율공시) (소규모합병 승인 이사회 결의(주주총회 갈음) 결과보고) M&A Activity	2024-11-20	Korean
[기재정정]기타경영사항(자율공시) (소규모합병 승인 이사회 결의(주주총회 갈음) 결과보고) AGM Information	2024-11-20	Korean
분기보고서 (2024.09) Interim / Quarterly Report 9M 2024	2024-11-14	Korean
[기재정정]주식등의대량보유상황보고서(일반) Major Shareholding Notification	2024-10-25	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2024-10-25	Korean
주식등의대량보유상황보고서(일반) Major Shareholding Notification	2024-10-25	Korean
[기재정정]주요사항보고서(회사합병결정) M&A Activity	2024-10-17	Korean
주요사항보고서(회사합병결정) M&A Activity	2024-10-14	Korean
투자판단관련주요경영사항 (유선종양에 이환된 개에서 수술 후 적용하는 항암병용치료제 (Vaxleukin-15 inj.) 품목허가 승인) Regulatory Filings	2024-08-08	Korean
주식매수선택권부여에관한신고 Share Issue/Capital Change	2024-07-12	Korean
주식등의대량보유상황보고서(약식) Major Shareholding Notification	2024-05-31	Korean
투자판단관련주요경영사항(임상시험결과) (진행성 간세포암 환자에서 자연살해세포와 간동맥주입화학요법 병합치료의 임상 2a상 연구 결과) Regulatory Filings	2024-05-22	Korean
[기재정정]주식등의대량보유상황보고서(일반) Major Shareholding Notification	2024-05-21	Korean
[기재정정]주식등의대량보유상황보고서(약식) Major Shareholding Notification	2024-05-21	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2024-05-21	Korean
분기보고서 (2024.03) Interim / Quarterly Report Q1 2024	2024-05-16	Korean
주식등의대량보유상황보고서(약식) Major Shareholding Notification	2024-05-13	Korean
주식등의대량보유상황보고서(일반) Major Shareholding Notification	2024-05-10	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2024-05-02	Korean
투자판단관련주요경영사항 (진행성 췌장암 환자에서 자연살해세포와 mFOLFIRINOX 병합치료의 임상 2a상 연구 임상시험계획 신청 반려) Legal Proceedings Report	2024-04-23	Korean
정기주주총회결과 Declaration of Voting Results & Voting Rights Announcements	2024-03-27	Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고 Board/Management Information	2024-03-27	Korean
사업보고서 (2023.12) Annual Report FY 2023	2024-03-19	Korean
감사보고서제출 Audit Report / Information FY 2023	2024-03-15	Korean
주주총회소집공고 Proxy Solicitation & Information Statement	2024-03-07	Korean
주주총회집중일개최사유신고 AGM Information	2024-03-07	Korean
의결권대리행사권유참고서류 Proxy Solicitation & Information Statement	2024-03-07	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2024-03-05	Korean
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2024-02-22	Korean
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2024-02-22	Korean
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2024-02-22	Korean
[기재정정]주식등의대량보유상황보고서(일반) Major Shareholding Notification	2024-02-22	Korean
[기재정정]주식등의대량보유상황보고서(일반) Major Shareholding Notification	2024-02-21	Korean
[기재정정]주식등의대량보유상황보고서(일반) Major Shareholding Notification	2024-02-21	Korean
[기재정정]주식등의대량보유상황보고서(일반) Major Shareholding Notification	2024-02-21	Korean
[기재정정]주식등의대량보유상황보고서(일반) Major Shareholding Notification	2024-02-21	Korean
[기재정정]주식등의대량보유상황보고서(일반) Major Shareholding Notification	2024-02-21	Korean
[기재정정]주식등의대량보유상황보고서(일반) Major Shareholding Notification	2024-02-21	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2024-02-21	Korean
주식등의대량보유상황보고서(일반) Major Shareholding Notification	2024-02-21	Korean
[기재정정]주주총회소집결의 AGM Information	2024-02-14	Korean
[기재정정]주식매수선택권부여에관한신고 Share Issue/Capital Change	2024-02-13	Korean
[기재정정]주식매수선택권부여에관한신고 Share Issue/Capital Change	2024-02-13	Korean
[기재정정]주식매수선택권부여에관한신고 Share Issue/Capital Change	2024-02-13	Korean
[기재정정]주식매수선택권부여에관한신고 Share Issue/Capital Change	2024-02-13	Korean
[기재정정]주식매수선택권부여에관한신고 Share Issue/Capital Change	2024-02-13	Korean
[기재정정]주식매수선택권부여에관한신고 Share Issue/Capital Change	2024-02-13	Korean
[기재정정]주식매수선택권부여에관한신고 Share Issue/Capital Change	2024-02-13	Korean
주식매수선택권부여에관한신고 Share Issue/Capital Change	2024-02-13	Korean
투자판단관련주요경영사항 (YBL-007 기술도입계약 체결의 건) Regulatory Filings	2024-02-13	Korean
주주총회소집결의 Proxy Solicitation & Information Statement	2024-02-13	Korean
[기재정정]투자판단관련주요경영사항 (YBL-007 기술도입계약 체결의 건) Regulatory Filings	2024-02-13	Korean
매출액또는손익구조30%(대규모법인은15%)이상변동 Earnings Release FY 2023	2024-02-07	Korean